Quantcast
Channel: mesotheliome.org
Viewing all articles
Browse latest Browse all 118

Genelux announces promising data from two phase I trials of GL-ONC1 in head and neck cancer and mesothelioma

$
0
0

Genelux Corporation, a clinical-stage biopharmaceutical company focused on the development of vaccinia virus for oncolytic immunotherapy, today announced that data from two Phase I trials…

Powered by WPeMatico


Viewing all articles
Browse latest Browse all 118

Trending Articles